What is the Forecasted Market Size and Growth Rates for the Global Immunodiagnostics Market?
The immunodiagnostics market size has grown substantially in recent years. It will increase from $22.88 billion in 2024 to $24.54 billion in 2025, marking a compound annual growth rate (CAGR) of 7.3%. The growth during the historic period can be attributed to the increasing incidence of infectious diseases, rise in autoimmune diseases, cancer diagnosis and monitoring, globalization of infectious diseases, public health initiatives, and screening programs.
Expected to see continued strong growth, the immunodiagnostics market is projected to reach $33.14 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. Factors contributing to this estimation include pandemic preparedness and response, personalized medicine and biomarker discovery, expanding healthcare infrastructure in emerging markets, integration with laboratory information systems, and rising burden of chronic diseases. Major trends in the forecasted period include multiplexing technologies, point-of-care testing (POCT), biomarker discovery and personalized medicine, the rise of digital immunodiagnostics, and a shift toward liquid biopsy.
Get Your Free Sample of The Global Immunodiagnostics Market Report at
https://www.thebusinessresearchcompany.com/sample.aspx?id=10093&type=smp
What Are the Key Driving Factors in the Immunodiagnostics Market Growth?
A significant driving factor for the immunodiagnostics market is the increasing prevalence of infectious diseases. These illnesses, caused by germs like viruses, bacteria, fungi, or parasites, are often diagnosed using an immunodiagnostic assay that identifies the presence of a virus in a blood sample. For instance, according to the US-based Centers for Disease Control and Prevention, tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, reflecting an increase of 1,295 cases. As such, the growing prevalence of infectious diseases is expected to boost the immunodiagnostics market.
What Are the Key Segments Within the Global Immunodiagnostics Market?
The immunodiagnostics market covered in this report is segmented as follows:
1) By Product: Reagents And Consumables, Instruments, Software And Services
2) By Technology: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test, Other Technologies
3) By Application: Infectious Diseases, Oncology And Endocrinology, Bone And Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications
4) By End User: Hospitals, Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users
Order your report now for swift delivery at
https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report
Who Are the Major Players in the Immunodiagnostics Market?
Major companies operating in the immunodiagnostics market include Abbott Laboratories, Arkray Inc., bioMérieux Inc., Immunodiagnostic Systems Holdings Plc (IDS), Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Siemens AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Qiagen N.V., Tecan Trading AG, PerkinElmer Inc., Merck KGaA, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Bio-Techne Corporation, Creative Diagnostics, Fujirebio Holdings Inc., Gold Standard Diagnostics Corp., Hologic Inc., Luminex Corporation, Myriad Genetics Inc., Natera Inc., OraSure Technologies Inc., Quidel Corporation.
What Are the Emerging Trends in the Immunodiagnostics Market?
Major companies in the immunodiagnostics market are focusing on the development of innovative solutions like the S. pneumoniae antigen immunodiagnostic assay for the diagnosis of pneumococcal pneumonia infection. This high-throughput solution allows for quick diagnoses and distinguishes pneumococcal pneumonia from other respiratory infections, to enhance clinical decision-making and effective antibiotic stewardship.
Which Region Is Set To Grow the Fastest in the Immunodiagnostics Market?
In 2024, North America was the most significant region in the immunodiagnostics market. The report covers regions such as Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Immunodiagnostics Market Report 2025 Offer?
Immunodiagnostics refers to a diagnostic methodology that mainly uses an antigen-antibody response for the detection of serum insulin. Immunodiagnostic tests are often used for identifying antibodies and parasite antigens. The Immunodiagnostics Market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Purchase the exclusive report now to unlock valuable market insights at
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10093
Contact Information:
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model